ABBOTT LABORATORIES — Director's Dealing 2014

Jan 31, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-01-29

Reporting Person: Warmuth Michael J (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-29	Common shares without par value	M	3103	$31.2621	Acquired	43590	Direct
2014-01-29	Common shares without par value	M	5404	$31.9012	Acquired	48994	Direct
2014-01-29	Common shares without par value	M	2923	$32.598	Acquired	51917	Direct
2014-01-29	Common shares without par value	S	11430	$36.2058	Disposed	40487	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-29	Option (right to buy)	$31.2621	M	3103	Disposed	2014-02-19	Common shares (3103)	Direct
2014-01-29	Option (right to buy)	$31.9012	M	5404	Disposed	2014-02-19	Common shares (5404)	Direct
2014-01-29	Option (right to buy)	$32.598	M	2923	Disposed	2014-02-19	Common shares (2923)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	25337	Indirect

Footnotes

F1: Held in the Stefanie M. Warmuth Revocable Trust. The reporting person and his spouse are trustees of the trust. The trust is revocable by the reporting person's spouse. The reporting person disclaims beneficial ownership of these securities.

F2: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.